STEPHANIE ROSE: Open Payments
NPI 1609315639 · SYLVANIA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,256 in 79 payments from 13 companies in 2025. Trend: 2023 $1,765 · 2024 $1,779 · 2025 $1,256
Food & beverage: $1,256
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $240 |
| Aimmune Therapeutics, Inc. | 16 | $164 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $152 |
| Madrigal Pharmaceuticals | 7 | $118 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $102 |
| QOL Medical, LLC | 5 | $96 |
| GENZYME CORPORATION | 4 | $80 |
| Phathom Pharmaceuticals, Inc. | 5 | $74 |
| Janssen Biotech, Inc. | 3 | $64 |
| VIVUS LLC | 3 | $57 |
Products named: ZENPEP, XIFAXAN, REZDIFFRA, Sucraid, DUPIXENT, CREON, VOQUEZNA, TREMFYA.
Industry payments across OH — which companies pay providers there.
